In human non-small cell lung cancer (NSCLC), low HBP1 protein expression is correlated with a poor prognosis in 82 NSCLC patients by immunohistochemical analysis; it was also associated with lymph node metastasis and early TMN stages32. This evidence concerns the gene HBP1 and metastatic malignant neoplasm in the lymph nodes.